PAX5 and acute lymphoblastic leukemia: In addition to structural rearrangements, previous studies have also identified recurrent and mutually exclusive mutations in the group of B-other cases, e.g., PAX5 p.P80R and IKZF1 p.N159Y, for which it was shown to drive the development of ALL [34,49,50].